Who Owns Vaxcyte Stock?
NASDAQ: PCVXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 113.46%
- Institutions (% of float)
- 114.03%
- Held by insiders
- 0.50%
- Institutional holders
- 458
- Institutions 99.5%
- Insiders 0.5%
- Public and other 0.0%
Who owns Vaxcyte stock?
Institutional investors own about 113.5% of Vaxcyte's shares, spread across 458 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.50% of PCVX.
The largest institutional holders are FMR, LLC (14.01%), Jupiter Topco LLC (12.07%) and T. Rowe Price Investment Management, Inc. (8.20%). Together, the top 10 institutions control 70.0% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their PCVX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PCVX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 20.85M | 14.01% | +26.4% |
| Jupiter Topco LLC | 17.97M | 12.07% | +100.0% |
| T. Rowe Price Investment Management, Inc. | 12.21M | 8.20% | +0.7% |
| Blackrock Inc. | 12.07M | 8.11% | +10.0% |
| RA Capital Management, L.P. | 11.47M | 7.71% | 0.0% |
| Wellington Management Group, LLP | 7.00M | 4.71% | +24.7% |
| Vanguard Portfolio Management LLC | 6.59M | 4.43% | +5.0% |
| Vanguard Capital Management LLC | 6.35M | 4.27% | +1.3% |
| State Street Corporation | 5.35M | 3.60% | +20.5% |
| Deep Track Capital, Lp | 4.30M | 2.89% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PCVX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.59M | 3.08% |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 4.01M | 2.69% |
| iShares Trust-iShares Russell 2000 ETF | 3.37M | 2.27% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.31M | 2.23% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 3.15M | 2.11% |
| JANUS INVESTMENT FUND-Janus Henderson Forty Fund | 2.68M | 1.80% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.34M | 1.57% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.31M | 1.55% |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 2.27M | 1.53% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.91M | 1.28% |
Frequently asked questions
Who is the largest shareholder of Vaxcyte?
FMR, LLC is the largest institutional shareholder of PCVX, owning 14.01% of shares outstanding (20.85M shares) as of its latest 13F filing.
What percentage of Vaxcyte is owned by institutions?
Institutions own about 113.5% of PCVX shares and 114.0% of the public float.
How much of Vaxcyte do insiders own?
Insiders, such as officers and directors, own about 0.50% of PCVX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.